New Discovery Paves Way for Understanding and Preventing Type 1 Diabetes

Scientists at Scripps Research have made a groundbreaking discovery that reveals a new kind of cell, known as vascular-associated fibroblastic cells (VAFs), plays a crucial role in protecting insulin-producing cells from autoimmune attacks. This finding sheds new light on the complex interactions between the immune system and the pancreas, and could lead to the development of novel therapies for type 1 diabetes.

Key Takeaways:

• VAFs act as molecular peacekeepers in the pancreas, actively protecting insulin-producing cells from the immune system.
• The discovery helps explain why type 1 diabetes often has a long preclinical phase, where the immune system begins to destroy insulin-producing cells but blood sugar levels remain normal.
• Enhancing VAFs' specialized functions could lead to the development of therapies that prevent or reverse type 1 diabetes.
• The protective nature of VAFs offers a new path for researchers to explore, shifting their focus from suppressing immunity to strengthening the body's natural tolerance mechanisms.
• The work also has broader implications for understanding other autoimmune diseases and organ transplantation.
• Researchers aim to develop personalized treatments that work with the body's own protective systems rather than against them.

Statistics:

• The pancreas faces unique immunological challenges, being constantly exposed to potential inflammatory triggers from food and the environment.
• 1.6 million Americans live with type 1 diabetes, managing the disease through multiple daily insulin injections, blood sugar monitoring, and a carefully regulated diet.
• Type 1 diabetics face serious, life-threatening risks if their blood sugar levels aren't within healthy ranges or well controlled.
• The Scripps Research team was awarded $3.2 million dollars by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to support their novel approach to understanding VAFs and developing new treatments.

Sources:

• Cell Reports, September 23, 2025, "A vascular-associated fibroblastic cell controls pancreatic islet immunity"
• The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Scripps Research Institute